Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

689 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry.
Mack M, Carroll JD, Thourani V, Vemulapalli S, Squiers J, Manandhar P, Deeb GM, Batchelor W, Herrmann HC, Cohen DJ, Hanzel G, Gleason T, Kirtane A, Desai N, Guibone K, Hardy K, Michaels J, DiMaio JM, Christensen B, Fitzgerald S, Krohn C, Brindis RG, Masoudi F, Bavaria J. Mack M, et al. Among authors: kirtane a. J Am Coll Cardiol. 2021 Dec 7;78(23):2326-2353. doi: 10.1016/j.jacc.2021.07.058. Epub 2021 Oct 25. J Am Coll Cardiol. 2021. PMID: 34711430 Free article.
Stent thrombosis after successful sirolimus-eluting stent implantation.
Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KK, Cohen DJ, Garcia LA, Cutlip DE, Carrozza JP Jr. Jeremias A, et al. Among authors: kirtane aj. Circulation. 2004 Apr 27;109(16):1930-2. doi: 10.1161/01.CIR.0000127105.99982.21. Epub 2004 Apr 12. Circulation. 2004. PMID: 15078797 Clinical Trial.
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
Karmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Karmpaliotis D, et al. Among authors: kirtane aj. Am J Cardiol. 2004 Nov 1;94(9):1113-7. doi: 10.1016/j.amjcard.2004.07.075. Am J Cardiol. 2004. PMID: 15518603 Clinical Trial.
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates.
Kirtane AJ, Leder DM, Waikar SS, Chertow GM, Ray KK, Pinto DS, Karmpaliotis D, Burger AJ, Murphy SA, Cannon CP, Braunwald E, Gibson CM; TIMI Study Group. Kirtane AJ, et al. J Am Coll Cardiol. 2005 Jun 7;45(11):1781-6. doi: 10.1016/j.jacc.2005.02.068. J Am Coll Cardiol. 2005. PMID: 15936606 Free article.
Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
Gibson CM, Karmpaliotis D, Kosmidou I, Murphy SA, Kirtane AJ, Budiu D, Ray KK, Herrmann HC, Lakkis N, Kovach R, French W, Blankenship J, Lui HH, Palabrica T, Jennings LK, Cohen DJ, Morrow DA; TIMI Study Group. Gibson CM, et al. Among authors: kirtane aj. Am J Cardiol. 2006 May 15;97(10):1473-7. doi: 10.1016/j.amjcard.2005.12.037. Epub 2006 Mar 29. Am J Cardiol. 2006. PMID: 16679086 Clinical Trial.
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.
Kirtane AJ, Piazza G, Murphy SA, Budiu D, Morrow DA, Cohen DJ, Peterson E, Lakkis N, Herrmann HC, Palabrica TM, Gibson CM; TIMI Study Group. Kirtane AJ, et al. J Am Coll Cardiol. 2006 Jun 20;47(12):2374-9. doi: 10.1016/j.jacc.2005.09.080. Epub 2006 May 30. J Am Coll Cardiol. 2006. PMID: 16781361 Free article. Clinical Trial.
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
Gibson CM, Kirtane AJ, Morrow DA, Palabrica TM, Murphy SA, Stone PH, Scirica BM, Jennings LK, Herrmann HC, Cohen DJ, McCabe CH, Braunwald E; TIMI Study Group. Gibson CM, et al. Among authors: kirtane aj. Am Heart J. 2006 Oct;152(4):756-61. doi: 10.1016/j.ahj.2006.04.016. Am Heart J. 2006. PMID: 16996854
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.
Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP Jr, Antman EM, Cannon CP, Gibson CM. Pinto DS, et al. Among authors: kirtane aj. Circulation. 2006 Nov 7;114(19):2019-25. doi: 10.1161/CIRCULATIONAHA.106.638353. Epub 2006 Oct 30. Circulation. 2006. PMID: 17075010
Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
Kumar R, Lee TT, Jeremias A, Ruisi CP, Sylvia B, Magallon J, Kirtane AJ, Bigelow B, Abrahamson M, Pinto DS, Ho KK, Cohen DJ, Carrozza JP Jr, Cutlip DE. Kumar R, et al. Among authors: kirtane aj. Am J Cardiol. 2007 Oct 15;100(8):1187-91. doi: 10.1016/j.amjcard.2007.05.038. Epub 2007 Aug 2. Am J Cardiol. 2007. PMID: 17920355
689 results